about
Reelin expression and glycosylation patterns are altered in Alzheimer's diseaseAltered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.Altered levels of acetylcholinesterase in Alzheimer plasma.Identification of a 31-bp deletion in the RELN gene causing lissencephaly with cerebellar hypoplasia in sheep.Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.Brain cholinergic impairment in liver failure.Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.CSF Presenilin-1 complexes are increased in Alzheimer's diseaseInhibition of γ-Secretase Leads to an Increase in Presenilin-1.ApoER2 processing by presenilin-1 modulates reelin expression.Changes in acetylcholinesterase expression are associated with altered presenilin-1 levels.Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice.Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide.Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.Acetylcholinesterase activation in organotypic rat hippocampal slice cultures deprived of oxygen and glucose.Acetylcholinesterase protein level is preserved in the Alzheimer's brain.Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats.Acetylcholinesterase modulates presenilin-1 levels and γ-secretase activity.Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.Biochemical properties of acetyl- and butyrylcholinesterase in human meningioma.Presenilin-1 influences processing of the acetylcholinesterase membrane anchor PRiMA.Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid.Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease.Monomers and dimers of acetylcholinesterase in human meningioma are anchored to the membrane by glycosylphosphatidylinositol.Molecular forms of acetyl- and butyrylcholinesterase in human glioma.Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effectCharacterization of molecular forms of acetyl- and butyrylcholinesterase in human acoustic neurinomasInhibition of neurite outgrowth from chick sympathetic neurons by cholinesterase inhibitors is not mediated by binding to cholinesterasesAltered glycosylation of acetylcholinesterase in the Creutzfeldt-Jakob cerebrospinal fluidCerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's diseaseQuantification of the transcripts encoding different forms of AChE in various cell types: real-time PCR coupled with standards in revealing the copy numberLevels of ADAM10 are reduced in Alzheimer's disease CSFCharacterization of Cerebrospinal Fluid BACE1 Species
P50
Q24541523-44B3B47B-AFED-49D9-B431-249198A80DC9Q31885641-CC502CDB-8C32-4BB1-8D7F-28301B10F2B5Q33592024-AD3E0514-1592-4C33-B0D8-F70733E517A6Q35049421-4FA09353-F55E-4334-8186-E51ED0760F72Q36540223-77C740DB-B8BF-457D-A5CB-D2825144F9BDQ36961030-BDE7822F-A3AB-498C-9CCF-71182E4A098EQ37191463-37B73AC1-902D-4B1E-8163-0980367E380AQ37485864-6E86EDEB-F9BA-41F0-9ADE-EC9794162175Q38641308-6AA4F753-51EA-4EE4-9A84-8A6EEAB66AF6Q39042682-F3C878A0-9DD6-4CFE-B88A-BD53307EDB22Q39534579-BEF954A6-6412-4514-A32E-B2216726A043Q39551014-E19BE09D-1D46-4AAB-8AFE-F987FC3587D0Q39760672-00D18B7B-2666-4B35-BF93-12B1B7053272Q40662936-6A148084-B1CC-4A5F-A6A7-FDCAAF14BFCEQ44014542-B41E8711-C0E9-4C2A-938E-5994F701B509Q44028773-4D17B9AC-6F2F-4DD1-B749-D33429FC7744Q44539136-EEB1F4ED-CEFA-41DA-8B59-B7273A24E44BQ45310728-22FADCDF-F726-4863-94A6-811B84731B70Q46528519-21DE55F0-ED4C-437A-AA47-A6B9D19F75F7Q46910159-A3D3DE9A-EE84-425D-918C-BFBE192893BAQ48251159-64E993AB-9CAC-40E0-9CE8-33C82C5D64FFQ48521123-1E9B2230-51B0-4C37-80EB-12722308C481Q48702612-B6F7ED73-7EE8-40B3-B8B6-F8AB7C4FC1E5Q48829218-249957BF-8785-419D-9F14-6245EFBA1D69Q50477395-F68B7024-2AD6-4833-B4AE-948A166E57D3Q53245378-6A9B84B2-24E2-4EEF-99E2-A443EBBA0BACQ53254173-93C7B8E0-C49E-4603-93E5-AF327A0A4C5AQ53327159-1137470E-4345-4690-A91F-77B699B923BBQ54165053-DA313BE2-16D6-4E57-A51B-1D821071DA6AQ55479803-FD03C956-82BF-4192-8AC7-B8FF40E18AF5Q73088625-67F5FA5E-36C4-4C92-9A15-234091793061Q73105149-3C454D82-AE51-4DC6-9F7B-11BFA71E931BQ77826973-102E220D-909F-48EC-90D2-57C07AD5E9C7Q79456353-C15E1DF7-D160-4625-B632-5B9F87FAA88CQ79841525-6DADCC41-B6FF-4D1B-B236-E0C47FE907D3Q87025880-1FF86E34-36BB-4054-A564-AE588B6E9728Q90472620-6CDF2FA0-7133-4EA8-B73A-2DFA6E88B177Q91759087-48C9C821-39DE-4C52-A659-F1D694D6FABD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier Sáez
@ast
Javier Sáez
@en
Javier Sáez
@es
Javier Sáez
@nl
Javier Sáez
@sl
type
label
Javier Sáez
@ast
Javier Sáez
@en
Javier Sáez
@es
Javier Sáez
@nl
Javier Sáez
@sl
altLabel
Javier Sáez-Valero
@en
prefLabel
Javier Sáez
@ast
Javier Sáez
@en
Javier Sáez
@es
Javier Sáez
@nl
Javier Sáez
@sl
P1053
K-5756-2014
P106
P21
P31
P3829
P496
0000-0001-7480-320X